Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial공중 보건 접근법에서 뉴클레오시드 역전사효소 억제제 교차 내성 및 2차 항레트로바이러스 요법의 결과: 무작위, 공개, EARNEST 시험 내 관찰 분석Articles Published on 2017-05-082022-09-06 Journal: The Lancet. HIV [Category] Communicable Disease, [키워드] AID Analysis Antiretroviral therapy ART assigned association baseline calculated clinical cooperation Cross-resistance Developing development European Evidence expected finding Follow-up funding Genotype genotypic greater impair inhibitor ISRCTN Lopinavir Medical Research Council monotherapy nucleoside Open-label outcome over partnership Patient patients with HIV predict predicted protease Protease inhibitor public health raltegravir randomised Randomised trial Randomly Registered Ritonavir sub-Saharan Africa Support Swedish tested therapy Treatment outcome Trial Viral Viral load Virological virological outcome virological outcomes WHO WHO criteria with HIV [DOI] 10.1016/S2352-3018(17)30065-6 PMC 바로가기 [Article Type] Articles
The association between development assistance for health and malaria, HIV and tuberculosis mortality: a cross-national analysisArticle Published on 2015-03-312024-09-10 Journal: J Epidemiol Glob Health [Category] 말라리아, [키워드] AID Development Assistance for Health Health aid HIV/AIDS malaria Tuberculosis PMC 바로가기
Retinoic acid and α-galactosylceramide regulate the expression of costimulatory receptors and transcription factors responsible for B cell activation and differentiation레티노산과 α-갈락토실세라미드는 보조자극 수용체와 B 세포 활성화 및 분화를 담당하는 전사 인자의 발현을 조절합니다journal-article Published on 2013-12-012024-07-30 Journal: Immunobiology [Category] 파상풍, [키워드] activation induced deaminase AID all-trans-retinoic acid CD138 CD19 CD40 CD86 GC Germinal center interferon regulatory factor IRF Pax-5 RA tetanus toxoid TT α-galactosylceramide αGalCer. [DOI] 10.1016/j.imbio.2013.05.003 [Article Type] journal-article